Organization
Methodist Hospital Research Institute
29 clinical trials
Clinical trial
A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast CancerStatus: Completed, Estimated PCD: 2021-07-01
Clinical trial
A Phase I Clinical Trial, Using Interleukin-2 (IL-2) and Abatacept in Patients With Frontotemporal DisordersStatus: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
Cannabidiol (CBD) As A Pain Adjunct in Orthopedic Surgical Patients: A Randomized Control TrialStatus: Recruiting, Estimated PCD: 2026-12-30
Clinical trial
A Phase I Trial to Evaluate Safety and Tolerability of Abatacept Followed by Subcutaneous Interleukin-2 Administration in Patients With Amyotrophic Lateral SclerosisStatus: Active (not recruiting), Estimated PCD: 2024-10-17
Clinical trial
Phase II Study of Docetaxel Chemotherapy With Pembrolizumab and Interleukin-12 Gene Therapy in Patients With Anthracycline- Refractory Triple Negative Breast Cancer (INTEGRAL)Status: , Estimated PCD: 2024-06-01
Clinical trial
Multicenter Phase II Trial of Durvalumab (MEDI4736) With Trastuzumab and Pertuzumab Combination in HER2-Enriched and HER2-Amplified Breast Cancer (DTP Trial)Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Clinical Phase Ib/II Trial of L-NMMA Plus Taxane Chemotherapy in the Treatment of Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer PatientsStatus: Completed, Estimated PCD: 2021-01-01
Clinical trial
A Phase II Clinical Trial of Neoadjuvant Sasanlimab and Stereotactic Body Radiation Therapy as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder CancerStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Venous Ethanol for Ischemic Left Ventricular TachycardiaStatus: Recruiting, Estimated PCD: 2027-12-12
Clinical trial
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without ChemotherapyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer and Metastatic Non-Small Cell Lung Cancer Followed by PembrolizumabStatus: Completed, Estimated PCD: 2022-07-22
Clinical trial
Comparison of 68 Ga-PSMA Positron Emission Tomography (PET)/CT to Conventional Imaging in Men With High Risk Prostate CancerStatus: Completed, Estimated PCD: 2022-02-26
Clinical trial
Intraosseous vs. Intravenous Vancomycin Administration in Total Shoulder Arthroplasty: Changing the ParadigmStatus: Recruiting, Estimated PCD: 2025-03-10
Clinical trial
Multicenter Safety Evaluation of Human Rabies Immune Globulin 300 IU/mL in ChildrenStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle ArthroplastyStatus: Recruiting, Estimated PCD: 2027-04-01
Clinical trial
Central and Peripheral Immune Cross-talk in Alzheimer's Disease and Their Modulation by a Novel ImmunotherapyStatus: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
Ocrelizumab for Psychoses Possibly Caused by Synaptic AutoimmunityStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Phase I-II Study Evaluating HSV-tK + VALACYCLOVIR GENE THERAPY Combination With Radiotherapy and Chemotherapy for Newly Diagnosed Anaplastic Astrocytoma and Glioblastoma Multiforme.Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Randomized Controlled Trial of cryoSPHERE (CRYOS/CRYOS-L) Ablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients Undergoing Robotic-Assisted Thoracoscopic SurgeryStatus: , Estimated PCD: 2025-03-15
Clinical trial
Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a ProtocolStatus: Completed, Estimated PCD: 2022-05-25
Clinical trial
Phase II Trial Of Fulvestrant Plus Abemaciclib In Er-Positive, Her2-Negative Metastatic Breast Cancer Immediately After Failure Of A Cdk4/6 InhibitorStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Phase II Trial of Alpelisib With iNOS Inhibitor and Nab-paclitaxel in Patients With HER2 Negative Metastatic or Locally Advanced Metaplastic Breast Cancer (MpBC)Status: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Phase I Trial Using Interleukin-2 (IL-2) to Expand Regulatory T Cells in Patients With Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2022-04-27
Clinical trial
Intraosseous Vancomycin vs Intravenous Vancomycin in Tourniquetless Primary Total Knee ArthroplastyStatus: Recruiting, Estimated PCD: 2024-01-25
Clinical trial
Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous MelanomaStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility StudyStatus: Recruiting, Estimated PCD: 2027-04-30
Clinical trial
Phase Ib Trial of L-NMMA in Combination With Pembrolizumab in Patients With Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Urothelial Carcinoma, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Merkel Cell Carcinoma, Primary Mediastinal Large B-cell Lymphoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Microsatellite Instability-High/Mismatch Repair Deficient Cancer, or for the Treatment of Adult Patients With Unresectable or Metastatic Tumor Mutational Burden-High Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2021-10-31
Clinical trial
A Phase II Clinical Trial of Interleukin-2 (IL-2) in Patients With Mild to Moderate Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2025-12-30